Shopping Cart
- Remove All
Your shopping cart is currently empty
m-PEG-NHS ester (MW 350) is utilized to modify active molecules, enhancing their antigenicity and immunogenicity, thus aiding in the preparation of injectable formulations. Modification of serine protease lumbrokinase (LK) with m-PEG-NHS ester does not affect its fibrinolytic and thrombolytic activities, indicating promising potential for application.
| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 25 mg | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | |
| 100 mg | Inquiry | Inquiry |
| Description | m-PEG-NHS ester (MW 350) is utilized to modify active molecules, enhancing their antigenicity and immunogenicity, thus aiding in the preparation of injectable formulations. Modification of serine protease lumbrokinase (LK) with m-PEG-NHS ester does not affect its fibrinolytic and thrombolytic activities, indicating promising potential for application. |
| Synonyms | mPEG-Succinimidyl ester (MW 350), mPEG-SC (MW 350), m-PEG-NHS ester (MW 350) |
| Molecular Weight | 350(Average) |
| Formula | (C2H4O)nC7H9NO5 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.